William Blair Starts Neumora Therapeutics (NMRA) at Outperform, 'fully funded through completion of the KOASTAL trials'
Tweet Send to a Friend
(Updated - October 10, 2023 7:01 AM EDT)
William Blair analyst Myles R. Minter initiates coverage on Neumora Therapeutics ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
William Blair analyst Myles R. Minter initiates coverage on Neumora Therapeutics ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
